|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Cash | |||||||||
| Prepaid expense | |||||||||
| Total current assets | |||||||||
| Intangible assets | |||||||||
| Other Assets | |||||||||
| Total Assets | |||||||||
| Accounts payable | |||||||||
| Due to a related party | |||||||||
| Due to a former related party | |||||||||
| Due to related parties | |||||||||
| Accruals | |||||||||
| Notes payable | |||||||||
| Total current liabilities | |||||||||
| Total Liabilities | |||||||||
| Preferred stock, $0.001 par value, 5,000,000 shares authorized, 300,000 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | |||||||||
| Preferred Stock | |||||||||
| Series A Preferred Stock | |||||||||
| Total preferred stock, $0.001 par value, 5,000,000 shares authorized, 300,000 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | |||||||||
| Common stock, $0.001 par value; 500,000,000 shares authorized, 115,893,597 and 100,521,335 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||||||
| Common stock to be issued | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Total stockholders' Equity | |||||||||
| Total Liabilities and Stockholders' Equity |
Loading...
